Patricia F. Ribeiro

Av. Prof. Alfredo Balena, 190
Belo Horizonte, MG 30130100, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis.

rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis.

Journal: Pathogens (Basel, Switzerland)

Published: December 07, 2022

Rational Design and Evaluation of the Recombinant Multiepitope Protein for Serodiagnosis of Rubella.

Rational Design and Evaluation of the Recombinant Multiepitope Protein for Serodiagnosis of Rubella.

Journal: Current pharmaceutical biotechnology

Published: April 13, 2021

Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.

Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.

Journal: Vaccines

Published: May 07, 2020

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.

Journal: NPJ vaccines

Published: January 31, 2020

Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice.

Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice.

Journal: Vaccines

Published: October 23, 2019

Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.

Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.

Journal: Parasitology research

Published: October 11, 2019

Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.

Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.

Journal: Cytokine

Published: October 11, 2019

Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach.

Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach.

Journal: Parasitology

Published: May 31, 2019

A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein.

A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein.

Journal: Immunobiology

Published: April 13, 2019

A Custom-Designed Recombinant Multiepitope Protein for Human Cytomegalovirus Diagnosis.

A Custom-Designed Recombinant Multiepitope Protein for Human Cytomegalovirus Diagnosis.

Journal: Recent patents on biotechnology

Published: April 10, 2019

Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls.

Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls.

Journal: Diagnostic microbiology and infectious disease

Published: December 20, 2018

A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.

A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.

Journal: Parasitology international

Published: December 17, 2018

Showing 1-12 of 35

Last Updated: 09/26/2026